美股A股
StockGist
Back
8-K2026-03-09· grok-4-1-fast-non-reasoning

DSGN · Design Therapeutics, Inc.

0001193125-26-098474

SEC filing

Summary

Design Therapeutics, Inc. issued a press release on March 9, 2026, announcing its financial results of operations and financial condition. The filing includes Exhibit 99.1, the press release, under Item 9.01.

Key takeaways